WHITEHOUSE STATION, N.J. (AP) — Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, itching and other symptoms temporarily.
Merck's latest application is for an allergy immunotherapy tablet for ragweed allergies that dissolves under the tongue. Patients in studies of the tablet took it daily for a year.
It could become an alternative to months of uncomfortable allergy shots. Both methods gradually desensitize the immune system to the substance triggering the allergic reaction.
In March, the Whitehouse Station, N.J., company said the FDA was reviewing its application for an immunotherapy tablet for grass pollen allergies.
Merck expects FDA rulings on both still-unnamed treatments in 2014's first half.
Huffington Post finds hidden thread in Hillary Clinton emails: Struggle for work-life balance
Showdown in Jackson Hole: The Fed Challenged on its Own Turf in Wyoming by Group Likely to Finally Start Dismantling It | Human Events
Duke Researcher Shows Cars are 80% Risker Than Guns - Bearing Arms -
Naming Names: A More Precise Look at Why The Republican Party is Dying | RedState
Katie Pavlich - WATCH: Sheriff David Clarke Takes on Cop Killer Advocate on CNN
Political Calculations - What Is Your U.S. Income Percentile Ranking?
The Federalist: Smoking guns in latest Hillary e-mail release? Update: Another? - Hot Air